The bill amends the North Dakota Century Code to update the classifications of controlled substances across several schedules, with a particular focus on Schedule I, III, and IV substances. It introduces a range of new substances, including various opiates, fentanyl derivatives, and synthetic cannabinoids, such as WIN 48,098 and UR-144. The bill also specifies that these new substances will be classified under Schedule I unless they are explicitly excepted or listed in another schedule. Additionally, it modifies the language regarding anabolic steroids, changing the term to "substances" and expanding the list to include new anabolic steroids like 6-bromo-androsta-1,4-diene-3,17-dione.

Furthermore, the bill removes certain outdated substances from the existing list, such as Methyl 3,3-dimethyl-2-[(1-pent-4-enylindazole-3-carbonyl)amino]butanoate, to ensure the legislation remains relevant to current trends in drug formulations. It also introduces Zuranolone as a new depressant and establishes a category for hallucinogenic substances, including the FDA-approved psilocybin composition COMP360. The bill allows the board to exempt specific compounds from regulation if they contain medicinal ingredients without central nervous system effects, emphasizing the urgency of these amendments in addressing public health concerns related to controlled substances.

Statutes affected:
INTRODUCED: 19-03.1-05, 19-03.1-09, 19-03.1-11
Adopted by the House Human Services Committee: 19-03.1-05, 19-03.1-09, 19-03.1-11
Enrollment: 19-03.1-05, 19-03.1-09, 19-03.1-11
PREFILED: 19-03.1-05, 19-03.1-09, 19-03.1-11